Home » Newsletters » BioWorld Science

BioWorld Science

April 11, 1997

View Archived Issues

UCSF receives NIH funding for research into anticancer protease inhibitors

Genentech granted U.S. patents for factor VIII

Selective 5-HT1Dalpha receptor agonists from MS&D

Astra prepares NOS inhibitors

Antiviral dihydropyrans from Biota

Synthelabo prepares serotonergic agents

Arzneimittelwerk describes novel antiepileptic agents

Synthelabo reports agents for urinary incontinence

First launch for new indication of cabergoline

Aldara approved in U.S.

MDR-reversing agents described by Nikken Chemicals

Fujsawa selects adenosine A1 receptor antagonist for development

Fujisawa describes new oral cephem antibiotic

Eisai prepares potent antitumor agents

TX-1877: new hypoxic cell radiation enhancer

Lilly granted rights to gene/protein involved in islet neogenesis

RPR cleared to market Taxotere in Malaysia and Hungary

Encouraging phase III results reported for lamivudine as hepatitis B treatment

Wyeth-Ayerst and Elan develop new formulation of Lodine

Milestone reached in Genome Therapeutics/Astra H. pylori collaboration

Progress in Cubist/Bristol-Myers Squibb antiinfective collaboration

Treatment for rhinitis undergoes further development in Australia

Hybridon selects HPV drug candidate

Encouraging results from preclinical trial of Atlantic's RSV therapy

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Feb. 4, 2025.
Today's news in brief
Briefs
BioWorld MedTech briefs for Jan. 30, 2026.
MicroRNAs in circulating extracellular vesicles as IPF biomarkers
BioWorld Science
MicroRNAs (miRNAs) are small noncoding RNAs gaining increasing attention due to their crucial role in gene expression regulation and influence in various cellular...
MJFF grant supports Bexorg’s translational biomarker work
BioWorld Science
Bexorg Inc. has been awarded a research grant from The Michael J. Fox Foundation for Parkinson’s Research (MJFF) through the Targets to Therapies initiative to...
REST emerges as biomarker in ALS, knockdown improves ALS symptoms
BioWorld Science
About 10% of amyotrophic lateral sclerosis (ALS) cases result from inherited genetic mutations, with about 20% of them attributed to mutations in the gene...